
LB Pharmaceuticals grants stock options to new SVP under Nasdaq inducement rule
LB Pharmaceuticals has granted Christopher Zergebel, its new Senior Vice President of Clinical Operations, an inducement equity award of 75,000 stock options. The options have a ten-year term, an exercise price of $32.95 per share, and vest over four...


